Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700020217

Trial Profile

Clinical Trials Insight: 700020217

Phase of Trial: Phase I/II

Latest Information Update: 19 Jun 2008

At a glance

  • Drugs Antineoplastics; MVA BN HER2
  • Indications Breast cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Bavarian Nordic
  • Most Recent Events

    • 19 Jun 2008 Interim results reported in a Bavarian Nordic media release (9090334).
    • 29 Apr 2008 Enrolment is continuing as planned, according to a Bavarian Nordic media release.
    • 29 Apr 2008 Results data is expected in quarter 2 2008, according to a Bavarian Nordic media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top